Medical 24 Limited - Limited company accounts 16.3
Medical 24 Limited - Limited company accounts 16.3
REGISTERED NUMBER: |
Strategic Report, Report of the Directors and |
Financial Statements for the Year Ended 30 September 2016 |
for |
Medical 24 Limited |
Medical 24 Limited (Registered number: 08705888) |
Contents of the Financial Statements |
for the Year Ended 30 September 2016 |
Page |
Company Information | 1 |
Strategic Report | 2 |
Report of the Directors | 3 |
Report of the Independent Auditors | 5 |
Profit and Loss Account | 6 |
Balance Sheet | 7 |
Cash Flow Statement | 8 |
Notes to the Cash Flow Statement | 9 |
Notes to the Financial Statements | 10 |
Medical 24 Limited |
Company Information |
for the Year Ended 30 September 2016 |
DIRECTORS: |
SECRETARY: |
REGISTERED OFFICE: |
REGISTERED NUMBER: |
AUDITORS: |
STATUTORY AUDITORS |
Medical 24 Limited (Registered number: 08705888) |
Strategic Report |
for the Year Ended 30 September 2016 |
The directors present their strategic report for the year ended 30 September 2016. |
REVIEW OF BUSINESS |
The Directors consider that the profit achieved on ordinary activities before taxation to be satisfactory. The downturn in |
turnover on prior years is due to changes within the healthcare sector and the NHS. |
2016 2015 2014 |
Turnover £3,314,016 £ 8,012,542 £2,212,165 |
Turnover growth (£4,698,526) £5,800,377 £2,212,165 |
Gross profit margin 31% 30% 30% |
Profit before tax 12% 16% 16% |
PRINCIPAL RISKS AND UNCERTAINTIES |
Medical 24 Limited had a satisfactory year and continue to supply staff to the healthcare sector. Due to the current |
economic conditions the Directors are aware of the need to monitor costs and have put policies in place to maintain |
stability and the profitability of the business. |
It is not considered necessary for an understanding of the development, performance or position of the company's |
business to comment here on environmental matters, the entity's employees or social, community and human rights |
issues. However, the company is very much aware and respectful of such matters and takes them in to account when |
planning and implementing business policy and procedures. |
ON BEHALF OF THE BOARD: |
Medical 24 Limited (Registered number: 08705888) |
Report of the Directors |
for the Year Ended 30 September 2016 |
The directors present their report with the financial statements of the company for the year ended 30 September 2016. |
DIVIDENDS |
No interim dividends were paid during the year ended 30 September 2016. |
The directors recommend final dividends per share as follows: |
Ordinary £1 shares | £7,526 |
A Ordinary £1 shares | NIL |
The total distribution of dividends for the year ended 30 September 2016 will be £ 752,680 . |
DIRECTORS |
The directors shown below have held office during the whole of the period from 1 October 2015 to the date of this |
report. |
Other changes in directors holding office are as follows: |
STATEMENT OF DIRECTORS' RESPONSIBILITIES |
The directors are responsible for preparing the Strategic Report, the Report of the Directors and the financial statements |
in accordance with applicable law and regulations. |
Company law requires the directors to prepare financial statements for each financial year. Under that law the directors |
have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting |
Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not |
approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the |
company and of the profit or loss of the company for that period. In preparing these financial statements, the directors |
are required to: |
- | select suitable accounting policies and then apply them consistently; |
- | make judgements and accounting estimates that are reasonable and prudent; |
- | state whether applicable accounting standards have been followed, subject to any material departures disclosed and explained in the financial statements; |
- | prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business. |
The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the |
company's transactions and disclose with reasonable accuracy at any time the financial position of the company and |
enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for |
safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud |
and other irregularities. |
STATEMENT AS TO DISCLOSURE OF INFORMATION TO AUDITORS |
So far as the directors are aware, there is no relevant audit information (as defined by Section 418 of the Companies Act |
2006) of which the company's auditors are unaware, and each director has taken all the steps that he or she ought to have |
taken as a director in order to make himself or herself aware of any relevant audit information and to establish that the |
company's auditors are aware of that information. |
Medical 24 Limited (Registered number: 08705888) |
Report of the Directors |
for the Year Ended 30 September 2016 |
AUDITORS |
The auditors, SHERIDAN CLARKE LTD, will be proposed for re-appointment at the forthcoming Annual General |
Meeting. |
ON BEHALF OF THE BOARD: |
Report of the Independent Auditors to the Members of |
Medical 24 Limited |
We have audited the financial statements of Medical 24 Limited for the year ended 30 September 2016 on pages six to |
thirteen. The financial reporting framework that has been applied in their preparation is applicable law and United |
Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice). |
This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the |
Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those |
matters we are required to state to them in a Report of the Auditors and for no other purpose. To the fullest extent |
permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's |
members as a body, for our audit work, for this report, or for the opinions we have formed. |
Respective responsibilities of directors and auditors |
As explained more fully in the Statement of Directors' Responsibilities set out on page three, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view. Our responsibility is to audit and express an opinion on the financial statements in accordance with applicable law and International Standards on Auditing (UK and Ireland). Those standards require us to comply with the Auditing Practices Board's Ethical Standards for Auditors. |
Scope of the audit of the financial statements |
An audit involves obtaining evidence about the amounts and disclosures in the financial statements sufficient to give |
reasonable assurance that the financial statements are free from material misstatement, whether caused by fraud or error. |
This includes an assessment of: whether the accounting policies are appropriate to the company's circumstances and |
have been consistently applied and adequately disclosed; the reasonableness of significant accounting estimates made by |
the directors; and the overall presentation of the financial statements. In addition, we read all the financial and |
non-financial information in the Strategic Report and the Report of the Directors to identify material inconsistencies with |
the audited financial statements and to identify any information that is apparently materially incorrect based on, or |
materially inconsistent with, the knowledge acquired by us in the course of performing the audit. If we become aware of |
any apparent material misstatements or inconsistencies we consider the implications for our report. |
Opinion on financial statements |
In our opinion the financial statements: |
- | give a true and fair view of the state of the company's affairs as at 30 September 2016 and of its profit for the year then ended; |
- | have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and |
- | have been prepared in accordance with the requirements of the Companies Act 2006. |
Opinion on other matter prescribed by the Companies Act 2006 |
In our opinion the information given in the Strategic Report and the Report of the Directors for the financial year for |
which the financial statements are prepared is consistent with the financial statements. |
Matters on which we are required to report by exception |
We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you |
if, in our opinion: |
- | adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or |
- | the financial statements are not in agreement with the accounting records and returns; or |
- | certain disclosures of directors' remuneration specified by law are not made; or |
- | we have not received all the information and explanations we require for our audit. |
for and on behalf of |
STATUTORY AUDITORS |
Medical 24 Limited (Registered number: 08705888) |
Profit and Loss Account |
for the Year Ended 30 September 2016 |
30.9.16 | 30.9.15 |
Notes | £ | £ |
TURNOVER |
Cost of sales |
GROSS PROFIT |
Administrative expenses |
OPERATING PROFIT | 3 |
Interest receivable and similar income |
PROFIT ON ORDINARY ACTIVITIES BEFORE TAXATION |
Tax on profit on ordinary activities | 4 |
PROFIT FOR THE FINANCIAL YEAR |
CONTINUING OPERATIONS |
None of the company's activities were acquired or discontinued during the current year or previous year. |
TOTAL RECOGNISED GAINS AND LOSSES |
The company has no recognised gains or losses other than the profits for the current year or previous year. |
Medical 24 Limited (Registered number: 08705888) |
Balance Sheet |
30 September 2016 |
30.9.16 | 30.9.15 |
Notes | £ | £ | £ | £ |
FIXED ASSETS |
Tangible assets | 6 |
CURRENT ASSETS |
Debtors | 7 |
Prepayments and accrued income |
Cash at bank |
CREDITORS |
Amounts falling due within one year | 8 |
NET CURRENT ASSETS |
TOTAL ASSETS LESS CURRENT LIABILITIES |
CAPITAL AND RESERVES |
Called up share capital | 9 |
Profit and loss account | 10 |
SHAREHOLDERS' FUNDS | 12 |
The financial statements were approved by the Board of Directors on |
Medical 24 Limited (Registered number: 08705888) |
Cash Flow Statement |
for the Year Ended 30 September 2016 |
30.9.16 | 30.9.15 |
Notes | £ | £ |
Net cash inflow |
from operating activities | 1 | 742,121 | 1,179,205 |
Returns on investments and |
servicing of finance | 2 | 1,979 | - |
Taxation | ( |
) | ( |
) |
Equity dividends paid | (752,680 | ) | (366,869 | ) |
(357,736 | ) | 731,239 |
Financing | 2 | - | 40 |
(Decrease)/increase in cash in the period | ( |
) |
Reconciliation of net cash flow |
to movement in net funds | 3 |
(Decrease)/increase in cash in the period | ( |
) |
Change in net funds resulting |
from cash flows | ( |
) |
Movement in net funds in the period | ( |
) |
Net funds/(debt) at 1 October | ( |
) |
Net funds at 30 September |
Medical 24 Limited (Registered number: 08705888) |
Notes to the Cash Flow Statement |
for the Year Ended 30 September 2016 |
1. | RECONCILIATION OF OPERATING PROFIT TO NET CASH INFLOW FROM OPERATING ACTIVITIES |
30.9.16 | 30.9.15 |
£ | £ |
Operating profit |
Depreciation charges | 1,091 | 1,451 |
Decrease/(increase) in debtors | 506,847 | (200,746 | ) |
(Decrease)/increase in creditors | (146,713 | ) | 53,220 |
Net cash inflow from operating activities | 742,121 | 1,179,205 |
2. | ANALYSIS OF CASH FLOWS FOR HEADINGS NETTED IN THE CASH FLOW STATEMENT |
30.9.16 | 30.9.15 |
£ | £ |
Returns on investments and servicing of finance |
Interest received | 1,979 | - |
Net cash inflow for returns on investments and servicing of finance | 1,979 | - |
Financing |
Share issue | - | 40 |
Net cash inflow from financing | - | 40 |
3. | ANALYSIS OF CHANGES IN NET FUNDS |
At | At |
1.10.15 | Cash flow | 30.9.16 |
£ | £ | £ |
Net cash: |
Cash at bank | (357,736 | ) |
690,315 | ( |
) | 332,579 |
Total | ( |
) |
Medical 24 Limited (Registered number: 08705888) |
Notes to the Financial Statements |
for the Year Ended 30 September 2016 |
1. | ACCOUNTING POLICIES |
Accounting convention |
The financial statements have been prepared under the historical cost convention and are in accordance with |
applicable accounting standards. |
Turnover |
Turnover comprises the invoiced value of services supplied by the company, all revenue is recognised in the |
Financial Statements as soon as the service has been supplied. |
Tangible fixed assets |
Fixtures and fittings | - |
Taxation |
Current tax, including UK Corporation tax is provided at amounts expected to be paid using the tax rates and |
laws enacted by the Balance Sheet date. |
Deferred tax is only provided for when material. The Director's have decided that deferred tax is not material this |
year, as was the case last year. |
2. | STAFF COSTS |
30.9.16 | 30.9.15 |
£ | £ |
Wages and salaries |
Social security costs |
The average monthly number of employees during the year was as follows: |
30.9.16 | 30.9.15 |
Administration | 3 | 3 |
Sales | 3 | 10 |
6 | 13 |
3. | OPERATING PROFIT |
The operating profit is stated after charging: |
30.9.16 | 30.9.15 |
£ | £ |
Depreciation - owned assets |
Auditors' remuneration |
Directors' remuneration |
Medical 24 Limited (Registered number: 08705888) |
Notes to the Financial Statements - continued |
for the Year Ended 30 September 2016 |
4. | TAXATION |
Analysis of the tax charge |
The tax charge on the profit on ordinary activities for the year was as follows: |
30.9.16 | 30.9.15 |
£ | £ |
Current tax: |
UK corporation tax |
Tax on profit on ordinary activities |
Factors affecting the tax charge |
The tax assessed for the year is higher than the standard rate of corporation tax in the UK. The difference is |
explained below: |
30.9.16 | 30.9.15 |
£ | £ |
Profit on ordinary activities before tax |
Profit on ordinary activities |
multiplied by the standard rate of corporation tax |
in the UK of |
Effects of: |
Expenses not deductible for tax purposes |
Depreciation in excess of capital allowances | - |
Current tax charge |
5. | DIVIDENDS |
30.9.16 | 30.9.15 |
£ | £ |
Ordinary shares of £1 each |
Final | 752,680 | 366,869 |
6. | TANGIBLE FIXED ASSETS |
Fixtures |
and |
fittings |
£ |
COST |
At 1 October 2015 |
and 30 September 2016 |
DEPRECIATION |
At 1 October 2015 |
Charge for year |
At 30 September 2016 |
NET BOOK VALUE |
At 30 September 2016 |
At 30 September 2015 |
Medical 24 Limited (Registered number: 08705888) |
Notes to the Financial Statements - continued |
for the Year Ended 30 September 2016 |
7. | DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
30.9.16 | 30.9.15 |
£ | £ |
Trade debtors | 183,054 | 753,139 |
Other debtors | 140 | 140 |
Tax overpaid | 59,121 | - |
8. | CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
30.9.16 | 30.9.15 |
£ | £ |
Trade creditors |
Tax |
Social security and other taxes |
Other creditors |
Accrued expenses | 4,800 | 12,042 |
See note 11 for details regarding Related Parties in Other creditors. |
9. | CALLED UP SHARE CAPITAL |
Allotted, issued and fully paid: |
Number: | Class: | Nominal | 30.9.16 | 30.9.15 |
value: | £ | £ |
A Ordinary | £1 |
Allotted and issued: |
Number: | Class: | Nominal | 30.9.16 | 30.9.15 |
value: | £ | £ |
Share capital 1 | £1 |
10. | RESERVES |
Profit |
and loss |
account |
£ |
At 1 October 2015 |
Profit for the year |
Dividends | ( |
) |
At 30 September 2016 |
Medical 24 Limited (Registered number: 08705888) |
Notes to the Financial Statements - continued |
for the Year Ended 30 September 2016 |
11. | RELATED PARTY DISCLOSURES |
K. Coyle, C. Coyle, D. Harrington, N. Poturicich, C. Safapour and A. Cooper are also Directors of Mayday |
Healthcare Plc, Mayday Direct 24 Plc, Plan B Healthcare Plc, VIP Nursing Limited and Pro Health 24 Limited. |
Further, K. Coyle, D. Harrington and A. Cooper are also Directors of Coyle Personnel Plc. At the year end, the |
company owed Coyle Personnel Plc £nil, 2015 £ 1,042 and Mayday Healthcare Plc £2,390, 2015 |
£ 577 for services supplied, these amounts have now been paid. |
No trading has been carried out between any of the Related Parties. Kevin Coyle holds the controlling interest in |
the company by virtue of ownership of 80% of the shares, his son Christopher owns the remaining 20%. All |
dividends were paid to shareholder Directors. |
12. | RECONCILIATION OF MOVEMENTS IN SHAREHOLDERS' FUNDS |
30.9.16 | 30.9.15 |
£ | £ |
Profit for the financial year |
Dividends | ( |
) | ( |
) |
New share capital subscribed | - | 40 |
Net (reduction)/addition to shareholders' funds | ( |
) |
Opening shareholders' funds |
Closing shareholders' funds |